SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-026569
Filing Date
2023-08-02
Accepted
2023-08-02 07:02:50
Documents
81
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ardx-20230630.htm   iXBRL 10-Q 1551341
2 EX-31.1 ardx-20230630xex311.htm EX-31.1 9756
3 EX-31.2 ardx-20230630xex312.htm EX-31.2 9778
4 EX-32.1 ardx-20230630xex321.htm EX-32.1 6454
10 ardx-20230630_g1.jpg GRAPHIC 75659
  Complete submission text file 0001628280-23-026569.txt   7643781

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ardx-20230630.xsd EX-101.SCH 58252
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ardx-20230630_cal.xml EX-101.CAL 66577
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ardx-20230630_def.xml EX-101.DEF 250490
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ardx-20230630_lab.xml EX-101.LAB 745924
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ardx-20230630_pre.xml EX-101.PRE 464238
75 EXTRACTED XBRL INSTANCE DOCUMENT ardx-20230630_htm.xml XML 958384
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36485 | Film No.: 231133686
SIC: 2834 Pharmaceutical Preparations